One caller during Tuesday's "Lightning Round" segment of Mad Money asked Jim Cramer about the company G1 Therapeutics (GTHX) : "This is a very speculative stock. As long as you understand that, you're OK," responded Cramer.
More from Investing
No strong emotions were seen going anywhere, but there are still some trades that can work amid the indifference.
They are all chasing the same people, the millennials.
That's not clear. What is clear, however, is that the charts of ACM are not particularly strong.
The charts of this Chinese agriculture tech firm are still pointed down.